Browsing: Catherine Harper-Wynne

Lifestyle

Breast cancer, Ribociclib, Cyclin-dependent kinase 4, Oncology, Medicine ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne

The EditorJune 22, 2023

Introduction The use of CDK46 inhibitors has become an important part of the treatment landscape for metastatic breast cancer. However,…